Cordlife Group Stock | P8A.SI | SG2E64980112 | A1JWVR

Date	Cordlife Group Price
12/20/2024	0.15 SGD
12/17/2024	0.16 SGD
12/16/2024	0.16 SGD
12/13/2024	0.16 SGD
12/12/2024	0.16 SGD
12/10/2024	0.15 SGD
12/6/2024	0.15 SGD
12/5/2024	0.15 SGD
11/29/2024	0.15 SGD
11/27/2024	0.15 SGD
11/26/2024	0.15 SGD
11/25/2024	0.16 SGD
11/22/2024	0.16 SGD

Date	Cordlife Group Revenue	Cordlife Group EBIT	Cordlife Group Net Income
2023	55.73 M SGD	-440,000 SGD	3.52 M SGD
2022	55.16 M SGD	1.51 M SGD	4.89 M SGD
2021	56.67 M SGD	4.9 M SGD	6.14 M SGD
2020	50.62 M SGD	-5.5 M SGD	6.55 M SGD
2019	61.58 M SGD	-2.93 M SGD	6.47 M SGD
2018	105.01 M SGD	5.5 M SGD	5.53 M SGD
2017	59.96 M SGD	824,000 SGD	-2.57 M SGD
2016	59.63 M SGD	1.66 M SGD	12.33 M SGD
2015	57.58 M SGD	5.83 M SGD	32.46 M SGD
2014	49.09 M SGD	9.01 M SGD	30.52 M SGD
2013	34.7 M SGD	7.4 M SGD	13.5 M SGD
2012	30.3 M SGD	5.6 M SGD	6.9 M SGD
2011	25.7 M SGD	7.2 M SGD	8.5 M SGD
2010	28.2 M SGD	8.4 M SGD	8.3 M SGD
2009	22.6 M SGD	7.1 M SGD	6.2 M SGD

	Revenue	EBIT	Net Income
2009	22.6 M SGD	7.1 M SGD	6.2 M SGD
2010	28.2 M SGD	8.4 M SGD	8.3 M SGD
2011	25.7 M SGD	7.2 M SGD	8.5 M SGD
2012	30.3 M SGD	5.6 M SGD	6.9 M SGD
2013	34.7 M SGD	7.4 M SGD	13.5 M SGD
2014	49.09 M SGD	9.01 M SGD	30.52 M SGD
2015	57.58 M SGD	5.83 M SGD	32.46 M SGD
2016	59.63 M SGD	1.66 M SGD	12.33 M SGD
2017	59.96 M SGD	824,000 SGD	-2.57 M SGD
2018	105.01 M SGD	5.5 M SGD	5.53 M SGD
2019	61.58 M SGD	-2.93 M SGD	6.47 M SGD
2020	50.62 M SGD	-5.5 M SGD	6.55 M SGD
2021	56.67 M SGD	4.9 M SGD	6.14 M SGD
2022	55.16 M SGD	1.51 M SGD	4.89 M SGD
2023	55.73 M SGD	-440,000 SGD	3.52 M SGD

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
22	28	25	30	34	49	57	59	59	105	61	50	56	55	55
-	27.27	-10.71	20.00	13.33	44.12	16.33	3.51	-	77.97	-41.90	-18.03	12.00	-1.79	-
72.73	71.43	72.00	70.00	73.53	69.39	70.18	66.10	64.41	67.62	63.93	62.00	69.64	67.27	67.27
16	20	18	21	25	34	40	39	38	71	39	31	39	37	37
6	8	8	6	13	30	32	12	-2	5	6	6	6	4	3
-	33.33	-	-25.00	116.67	130.77	6.67	-62.50	-116.67	-350.00	20.00	-	-	-33.33	-25.00
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
210.9	210.9	210.9	171.7	232.6	256.59	260.34	259.77	259.37	254.29	254.63	256.37	256.23	255.75	256.29
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022

9.8	8.2	5.3	18.9	11.8	45.41	29.23	138.07	60.57	43.27	38.26	62.41	64.63	65.17
14	11.9	6.8	8.6	12.1	12.89	15.26	21.01	24.46	28.97	24.04	23.39	23.96	25.48
0.2	0.3	0.2	0.6	0.9	0.73	3.25	1.67	1.62	7.86	4.61	3.66	7.38	4.06
0.2	0.2	0.2	0.4	0.4	0.65	0.85	1.06	1.28	1.36	1.34	1.66	1.43	1.36
0.2	0.4	0.4	0.6	1.9	2.35	2.98	2.39	2.5	3.42	13.88	12.78	2.42	11.69
24.4	21	12.9	29.1	27.1	62.02	51.57	164.2	90.42	84.87	82.13	103.89	99.82	107.76
0.8	2	4.3	6.1	7.6	8.41	9.56	13.29	13.06	12.72	16.09	16.43	16.4	14.42
0	14.5	15.1	19.2	33.3	72.14	78.2	13.35	14.43	14.9	22.73	11.54	18.71	10.88
17.4	21.1	22.9	24.3	39	45.98	153.12	64.72	67.3	67.59	69.81	68.25	66.57	63.6
0.1	0	0	0	1.8	1.94	2.55	6.68	5.82	6.38	5.68	4.56	31.54	3.46
0	0	0	0	0	0	0	8.01	7.7	27.88	27.74	27.41	0	26.99
0	0.2	0.2	11.7	11.7	0.21	37.97	0.33	0	0.15	0.1	1.14	0.67	0.89
18.3	37.8	42.5	61.3	93.4	128.68	281.4	106.38	108.31	129.61	142.14	129.33	133.89	120.23
42.7	58.8	55.4	90.4	120.5	190.71	332.96	270.57	198.73	214.48	224.27	233.22	233.71	228

25.7	25.7	25.7	53.5	53.5	96.66	96.66	96.67	96.67	96.38	95.99	95.65	95.16	94.69
0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.3	7.4	15.9	18.1	25.1	50.32	77.7	51.94	41.82	44.21	51.62	55.47	54.56	51.93
0	0	-1	-0.5	-0.9	-1.61	-2.05	-8.09	-3.56	-3.92	-3.77	-3.95	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0
27	33.1	40.6	71.1	77.7	145.37	172.31	140.52	134.93	136.67	143.85	147.17	149.72	146.62
4.2	13.1	0.5	0.8	4.7	0.91	2.86	3.86	3.02	4.14	3.26	4.65	11.42	3.69
0.9	1.4	1.3	1.6	1.3	4.14	5.61	4.52	3.57	5.3	6.33	5.21	0	2.91
5.7	5.8	6.2	5.8	10.9	10.77	8.22	21.23	22.2	25.54	14.04	14.66	10.69	13.09
1.1	0.8	0	0	0	3.5	3.5	1.06	1.27	0	0	0	0	0
0	0	0.1	0.1	0.3	0.95	0.99	2.12	2.12	0.3	1.44	1.89	2.12	1.2
11.9	21.1	8.1	8.3	17.2	20.27	21.18	32.8	32.18	35.27	25.07	26.4	24.24	20.89
0	0	0.8	2.5	5.9	8.4	124.82	76.15	6.61	4.31	5.35	5.76	0.84	1.02
0	0	0.1	0.1	0.2	0.19	0.09	4.07	3.89	7.07	5.21	4.63	4.17	3.96
2.6	4.6	5.9	8.4	19.6	20.55	24.93	24.8	30.72	46.5	59.37	63.2	67.77	67.8
2.6	4.6	6.8	11	25.7	29.14	149.84	105.02	41.23	57.87	69.93	73.59	72.78	72.78
14.5	25.7	14.9	19.3	42.9	49.42	171.02	137.82	73.4	93.14	95	99.99	97.02	93.67
41.5	58.8	55.5	90.4	120.6	194.79	343.32	278.33	208.33	229.81	238.85	247.16	246.74	240.28

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
7	9	9	7	14	31	33	13	-1	8	8	7	7	5	4
0	0	0	0	0	1	1	2	3	4	4	4	3	3	4
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-4	-1	0	-2	0	-7	-11	-5	0	-3	8	12	0	0	3
0	0	-1	0	-6	-22	-27	-14	2	1	-9	-8	0	-3	-4
0	0	0	0	0	0	3	5	2	0	0	0	0	0	0
0	1	1	1	0	1	1	1	0	1	3	0	0	1	1
3	8	8	6	8	3	-3	-4	4	10	11	15	9	5	7
0	-1	-3	-2	-1	-1	-2	-5	-1	-2	-2	-1	-1	-2	-2
-3	-16	-4	-20	-10	-9	-115	168	30	-9	4	-1	-23	4	-2
-2	-14	-1	-17	-8	-7	-112	174	32	-6	6	0	-22	6	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	1	3	6	115	-53	-71	-6	0	0	-3	0	0
0	0	0	29	0	0	-6	0	0	-6	0	0	0	0	0
1	9	-7	23	-3	30	101	-110	-78	-16	-12	-2	3	-11	0
1	9	-8	-3	0	0	-2	-20	-6	0	-10	0	9	-9	0
0	0	0	-4	-6	-5	-5	-36	0	-3	-1	-2	-2	-2	0
2	1	-3	8	-4	24	-16	53	-43	-15	3	11	-10	-2	5
3.38	6.72	4.98	3.62	6.76	1.82	-6.24	-9.77	2.35	7.41	9.55	14.53	7.93	3.55	5.11
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cordlife Group Gross margin	Cordlife Group Profit margin	Cordlife Group EBIT margin	Cordlife Group Profit margin
2023	66.94 %	-0.79 %	6.32 %
2022	67.43 %	2.74 %	8.86 %
2021	69.67 %	8.65 %	10.83 %
2020	62.7 %	-10.86 %	12.93 %
2019	64.45 %	-4.75 %	10.51 %
2018	67.68 %	5.24 %	5.27 %
2017	64.75 %	1.37 %	-4.29 %
2016	66.18 %	2.79 %	20.68 %
2015	69.5 %	10.13 %	56.37 %
2014	71.01 %	18.36 %	62.18 %
2013	72.91 %	21.33 %	38.9 %
2012	70.96 %	18.48 %	22.77 %
2011	71.21 %	28.02 %	33.07 %
2010	72.7 %	29.79 %	29.43 %
2009	72.57 %	31.42 %	27.43 %

	Gross margin	EBIT margin	Profit margin
2009	72.57 %	31.42 %	27.43 %
2010	72.7 %	29.79 %	29.43 %
2011	71.21 %	28.02 %	33.07 %
2012	70.96 %	18.48 %	22.77 %
2013	72.91 %	21.33 %	38.9 %
2014	71.01 %	18.36 %	62.18 %
2015	69.5 %	10.13 %	56.37 %
2016	66.18 %	2.79 %	20.68 %
2017	64.75 %	1.37 %	-4.29 %
2018	67.68 %	5.24 %	5.27 %
2019	64.45 %	-4.75 %	10.51 %
2020	62.7 %	-10.86 %	12.93 %
2021	69.67 %	8.65 %	10.83 %
2022	67.43 %	2.74 %	8.86 %
2023	66.94 %	-0.79 %	6.32 %

Date	Cordlife Group Sales per Share	Cordlife Group EBIT per share	Cordlife Group Earnings per Share
2023	0.22 SGD	-0 SGD	0.01 SGD
2022	0.22 SGD	0.01 SGD	0.02 SGD
2021	0.22 SGD	0.02 SGD	0.02 SGD
2020	0.2 SGD	-0.02 SGD	0.03 SGD
2019	0.24 SGD	-0.01 SGD	0.03 SGD
2018	0.41 SGD	0.02 SGD	0.02 SGD
2017	0.23 SGD	0 SGD	-0.01 SGD
2016	0.23 SGD	0.01 SGD	0.05 SGD
2015	0.22 SGD	0.02 SGD	0.12 SGD
2014	0.19 SGD	0.04 SGD	0.12 SGD
2013	0.15 SGD	0.03 SGD	0.06 SGD
2012	0.18 SGD	0.03 SGD	0.04 SGD
2011	0.12 SGD	0.03 SGD	0.04 SGD
2010	0.13 SGD	0.04 SGD	0.04 SGD
2009	0.11 SGD	0.03 SGD	0.03 SGD

	Sales per Share	EBIT per share	Earnings per Share
2009	0.11 SGD	0.03 SGD	0.03 SGD
2010	0.13 SGD	0.04 SGD	0.04 SGD
2011	0.12 SGD	0.03 SGD	0.04 SGD
2012	0.18 SGD	0.03 SGD	0.04 SGD
2013	0.15 SGD	0.03 SGD	0.06 SGD
2014	0.19 SGD	0.04 SGD	0.12 SGD
2015	0.22 SGD	0.02 SGD	0.12 SGD
2016	0.23 SGD	0.01 SGD	0.05 SGD
2017	0.23 SGD	0 SGD	-0.01 SGD
2018	0.41 SGD	0.02 SGD	0.02 SGD
2019	0.24 SGD	-0.01 SGD	0.03 SGD
2020	0.2 SGD	-0.02 SGD	0.03 SGD
2021	0.22 SGD	0.02 SGD	0.02 SGD
2022	0.22 SGD	0.01 SGD	0.02 SGD
2023	0.22 SGD	-0 SGD	0.01 SGD

	Number of stocks
2009	210.9 M Aktien
2010	210.9 M Aktien
2011	210.9 M Aktien
2012	171.7 M Aktien
2013	232.6 M Aktien
2014	256.59 M Aktien
2015	260.34 M Aktien
2016	259.77 M Aktien
2017	259.37 M Aktien
2018	254.29 M Aktien
2019	254.63 M Aktien
2020	256.37 M Aktien
2021	256.23 M Aktien
2022	255.75 M Aktien
2023	256.29 M Aktien

Date	Cordlife Group Dividend
2022	0.01 SGD
2021	0.01 SGD
2020	0.01 SGD
2019	0 SGD
2018	0.01 SGD
2017	0.01 SGD
2015	0.15 SGD
2014	0.02 SGD
2013	0.02 SGD
2012	0.02 SGD

	Dividend	Dividend (Estimate)
2009	0 SGD	0 SGD
2010	0 SGD	0 SGD
2011	0 SGD	0 SGD
2012	0.02 SGD	0 SGD
2013	0.02 SGD	0 SGD
2014	0.02 SGD	0 SGD
2015	0.15 SGD	0 SGD
2016	0 SGD	0 SGD
2017	0.01 SGD	0 SGD
2018	0.01 SGD	0 SGD
2019	0 SGD	0 SGD
2020	0.01 SGD	0 SGD
2021	0.01 SGD	0 SGD
2022	0.01 SGD	0 SGD
2023	0 SGD	0 SGD

Date	Cordlife Group Payout ratio
2023	41.28 %
2022	47.1 %
2021	37.59 %
2020	39.15 %
2019	15.74 %
2018	36.76 %
2017	-50.4 %
2016	41.28 %
2015	120.31 %
2014	16.81 %
2013	33.33 %
2012	50 %
2011	41.28 %
2010	41.28 %
2009	41.28 %

	Payout ratio
2009	41.28 %
2010	41.28 %
2011	41.28 %
2012	50 %
2013	33.33 %
2014	16.81 %
2015	120.31 %
2016	41.28 %
2017	-50.4 %
2018	36.76 %
2019	15.74 %
2020	39.15 %
2021	37.59 %
2022	47.1 %
2023	41.28 %

%	Name	Stocks	Change	Date
26.71114 %	TransGlobal Real Estate Group Limited	71,460,300	0	3/20/2023
19.38848 %	Nanjing Xinjiekou Department Store Co. Ltd.	51,870,000	0	8/2/2024
9.53787 %	Kang (Lan)	25,516,666	25,516,666	8/2/2024
4.78451 %	Cedar Tree Investment Ltd	12,800,000	0	3/20/2023
3.51626 %	China Minsheng Investment Group (CMIG)	9,407,060	-8,725,940	1/23/2024
1.16137 %	Coop International Pte. Ltd.	3,107,000	0	3/20/2023
0.95951 %	Tantalum Cellular Products LLC	2,566,972	0	3/20/2023
0.43572 %	Tan (Poh Lan)	1,165,680	0	2/19/2024
0.30095 %	Thet (Hnin Yi)	805,120	0	3/20/2023
0.29606 %	Ho (Choon Hou)	792,061	0	1/21/2023
0.18240 %	Kheng (May Lian Susan)	487,970	0	3/20/2023
0.18211 %	Lee (In Chun)	487,200	0	3/20/2023
0.16411 %	Chan (Cheng Lock)	439,050	15,000	3/20/2023
0 %	Global Cord Blood Corp	0	-25,516,666	8/2/2024

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation
Global Cord Blood	SupplierCustomer	0,54	0,15	0,01	0,18
Eone Diagnomics Genome	SupplierCustomer	0,36	0,51	-0,04	0,36	0,26
Nanjing Xinjiekou A	SupplierCustomer	-0,04	-0,10			0,04

What values and corporate philosophy does Cordlife Group represent?

Cordlife Group Ltd represents a commitment to providing advanced cord blood and tissue banking services. Their corporate philosophy revolves around prioritizing the healthcare needs of families. Cordlife aims to offer secure storage for umbilical cord blood, which contains valuable stem cells that have potential therapeutic applications. They believe in empowering individuals and the medical community with access to these life-saving resources, helping to pave the way for advancements in regenerative medicine. Cordlife Group Ltd recognizes the importance of investing in technology and research to continually improve their services and contribute to the field of stem cell science.

In which countries and regions is Cordlife Group primarily present?

Cordlife Group Ltd is primarily present in several countries and regions. The company has a strong presence in Singapore, where it is headquartered. It is also actively operating in Hong Kong, India, Indonesia, Malaysia, and the Philippines. Cordlife Group Ltd has established cord blood banks and stem cell facilities in these countries, offering various services and products related to cord blood banking and umbilical cord stem cell preservation. With its extensive network and expertise, Cordlife Group Ltd continues to expand and provide reliable services to families seeking to store their newborn's cord blood for future medical use.

What significant milestones has the company Cordlife Group achieved?

Cordlife Group Ltd has achieved several significant milestones in its history. One of the notable achievements was the successful IPO listing on the Singapore Exchange Securities Trading Limited in 2011. This milestone not only demonstrated the company's strong market position but also opened up new opportunities for growth and expansion. Furthermore, Cordlife Group Ltd has consistently expanded its presence in the international market, establishing a strong foothold in countries like Hong Kong, India, and the Philippines. Additionally, the company has received several prestigious awards and recognition for its commitment to quality and excellence in stem cell banking services. These achievements have solidified Cordlife Group Ltd's position as a leading player in the industry.

What is the history and background of the company Cordlife Group?

Cordlife Group Ltd is a leading consumer healthcare group, dedicated to providing stem cell banking and cord blood services. Founded in 2001, Cordlife has a rich history of delivering high-quality stem cell banking solutions to families in Asia-Pacific. With a strong focus on innovation and research, Cordlife has established a reputation for its state-of-the-art laboratory facilities and commitment to exceptional service. As a pioneer in the field, Cordlife has successfully stored and preserved thousands of cord blood units, offering opportunities for future medical treatments and therapies. With a strong track record and a dedicated team of professionals, Cordlife Group Ltd continues to pave the way in the stem cell banking industry.

Who are the main competitors of Cordlife Group in the market?

The main competitors of Cordlife Group Ltd in the market are StemLife, Cryoviva, and Cryo-Save.

In which industries is Cordlife Group primarily active?

Cordlife Group Ltd is primarily active in the healthcare industry.

What is the business model of Cordlife Group?

Cordlife Group Ltd operates with a business model focused on providing cord blood banking and cord tissue banking services. As a leading consumer healthcare company, Cordlife Group offers expectant parents the opportunity to store their baby's umbilical cord blood and tissue, which contain potentially life-saving stem cells. These stem cells can be used in the future for various medical treatments, including cancer, blood disorders, and immune system disorders. Cordlife Group ensures that the collected stem cells are processed, tested, and stored under strict quality standards, ensuring their viability and safety for potential future use.

What is the P/E ratio of Cordlife Group 2024?

The P/E ratio cannot be calculated for Cordlife Group at the moment.

What is the P/S ratio of Cordlife Group 2024?

The P/S cannot be calculated for Cordlife Group currently.

What is the Quality Investing of Cordlife Group?

The Quality Investing for Cordlife Group is 2/10.

What is the revenue of Cordlife Group 2024?

The revenue cannot currently be calculated for Cordlife Group.

How high is the profit of Cordlife Group 2024?

The profit cannot currently be calculated for Cordlife Group.

What is the business model of Cordlife Group

Cordlife Group Ltd is a biotechnology company specializing in stem cell storage. The company offers various products and services tailored to the needs of families and medical professionals. Cordlife operates stem cell storage banks in various countries, including Australia, Hong Kong, India, Indonesia, Malaysia, Philippines, Singapore, and Thailand. The facilities are certified to the highest international quality standards and provide a safe and reliable solution for stem cell storage. The company offers various stem cell products, including umbilical cord blood, umbilical cord tissue, and placental tissue. These products can be used for various diseases and conditions, such as leukemia, sickle cell anemia, thalassemia, autism, cerebral palsy, and diabetes. Cordlife also offers services for the collection of umbilical cord blood and umbilical cord tissue. The company works with selected medical facilities to ensure safe and effective collection. Umbilical cord blood collection is a simple and non-invasive method that can be done during childbirth. Cordlife also has a research and development department focused on the development of new technologies and products. The company strives to constantly improve its services and provide innovative solutions to enhance the health and well-being of people worldwide. The business model of Cordlife Group Ltd is based on stem cell storage and providing products and services tailored to the needs of families and medical professionals. The company utilizes state-of-the-art technologies and facilities to ensure safe and effective storage and collection of stem cells. The company has a strong focus on research and development of new technologies and products to ensure it stays at the forefront of science. This allows the company to improve its services and offer innovative solutions to enhance the health and well-being of people worldwide. Cordlife Group Ltd has a strong presence in Asia and is constantly expanding into new regions and countries. The company works closely with medical facilities and professionals to continuously improve and optimize its services. In conclusion, Cordlife Group Ltd is a biotechnology company specializing in stem cell storage and provision of stem cell products and services. The company has a strong focus on research and development of new technologies and products to ensure it stays at the forefront of science. With its strong emphasis on quality and customer service, Cordlife Group Ltd is expected to remain a leading player in the biotechnology industry.

What is the Cordlife Group dividend?

Cordlife Group pays a dividend of 0.01 SGD distributed over payouts per year.

How often does Cordlife Group pay dividends?

The dividend cannot currently be calculated for Cordlife Group or the company does not pay out a dividend.

What is the Cordlife Group ISIN?

The ISIN of Cordlife Group is SG2E64980112.

What is the Cordlife Group WKN?

The WKN of Cordlife Group is A1JWVR.

What is the Cordlife Group ticker?

The ticker of Cordlife Group is P8A.SI.

How much dividend does Cordlife Group pay?

Over the past 12 months, Cordlife Group paid a dividend of 0.01 SGD . This corresponds to a dividend yield of about 6.16 %. For the coming 12 months, Cordlife Group is expected to pay a dividend of 0.01 SGD.

What is the dividend yield of Cordlife Group?

The current dividend yield of Cordlife Group is 6.16 %.

When does Cordlife Group pay dividends?

Cordlife Group pays a quarterly dividend. This is distributed in the months of May, July, June, June.

How secure is the dividend of Cordlife Group?

Cordlife Group paid dividends every year for the past 0 years.

What is the dividend of Cordlife Group?

For the upcoming 12 months, dividends amounting to 0.01 SGD are expected. This corresponds to a dividend yield of 6.16 %.

In which sector is Cordlife Group located?

Cordlife Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cordlife Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cordlife Group from 5/27/2022 amounting to 0.009 SGD, you needed to have the stock in your portfolio before the ex-date on 5/6/2022.

When did Cordlife Group pay the last dividend?

The last dividend was paid out on 5/27/2022.

What was the dividend of Cordlife Group in the year 2023?

In the year 2023, Cordlife Group distributed 0.009 SGD as dividends.

In which currency does Cordlife Group pay out the dividend?

The dividends of Cordlife Group are distributed in SGD.

Cordlife Group Ticker	Cordlife Group FIGI
CLGL:SP	BBG002QJRSW9
CLIFF:US	BBG003M7JPR8
CLIFF:PQ	BBG003M7JQ50
CLIFF:UV	BBG003M7JQ78
CLGLSGD:XH	BBG00ZV6NKR5
CLGLSGD:XF	BBG00ZV6NKT3
CLGLSGD:XE	BBG00ZV6NKW9
CLGLSGD:XL	BBG00ZV6NKY7
CLGLSGD:XG	BBG00ZV6NKZ6
CLGLSGD:XO	BBG00ZV6NL02
CLGLSGD:XA	BBG00ZV6NL48
CLGLSGD:XT	BBG00ZV6NL66
CLGLSGD:XW	BBG00ZV6NL75
CLGLSGD:XU	BBG00ZV6NL84
CLGLSGD:XV	BBG00ZV6NLB0
CLGLSGD:XM	BBG00ZV6NLC9
CLGLSGD:EU	BBG00ZV6NLL9

Access the world's leading financial data and tools

Price

Price

TickerP8A.SI

ISINSG2E64980112

WKNA1JWVR

Cordlife Group stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Cordlife Group Stock Price History

Cordlife Group Revenue, EBIT, Net Income SG2E64980112 · A1JWVR

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Cordlife Group Revenue, EBIT and net profit per share

Cordlife Group Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Cordlife Group stock margins SG2E64980112 · A1JWVR

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Cordlife Group Margin History

Cordlife Group Stock Sales Revenue, EBIT, Earnings per Share SG2E64980112 · A1JWVR

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Cordlife Group Revenue, EBIT and net profit per share

Cordlife Group business model

Cordlife Group SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

Cordlife Group Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Cordlife Group historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

Cordlife Group shares outstanding SG2E64980112 · A1JWVR

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Cordlife Group dividend history and estimates SG2E64980112 · A1JWVR

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Cordlife Group Dividend History

Ticker
P8A.SI

ISIN
SG2E64980112

WKN
A1JWVR